First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

Statistical parametric maps in functional imaging: A general linear approach

Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688

Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

Coyle, J. T., Tsai, G. E., & GOFF, D. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.020 · Cited by 443

Usefulness of a three-dimensional stereotaxic ROI template on anatomically standardised 99mTc-ECD SPET

Takeuchi, R., Yonekura, Y., Matsuda, H., & Konishi, J. (2002) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-001-0715-z · Cited by 134

Impact of Schizophrenia and Chronic Antipsychotic Treatment on [123I]CNS-1261 Binding to N-Methyl-D-Aspartate Receptors In Vivo

Bressan, R. A., Erlandsson, K., Stone, J. M., Mulligan, R. S., Krystal, J. H., Ell, P. J., & Pilowsky, L. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.016 · Cited by 57

Kinetic modelling of [123I]CNS 1261—a potential SPET tracer for the NMDA receptor

Erlandsson, K., Bressan, R. A., Mulligan, R. S., Gunn, R. N., Cunningham, V. J., Owens, J., Wyper, D. J., Ell, P. J., & Pilowsky, L. S. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00450-x · Cited by 40

Untitled work

Lurito (2000) · doi:10.1002/1097-0193(200007)10:3

Longitudinal trajectories of anterior cingulate glutamate and subclinical psychotic experiences in early adolescence: the impact of bullying victimization

Okada, N., Yahata, N., Koshiyama, D., Morita, K., Sawada, K., Kanata, S., Fujikawa, S., Sugimoto, N., Toriyama, R., Masaoka, M., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02382-8 · Cited by 7

Imaging the glutamate synapse

Krystal, J. H. (2020) · Nature Medicine · doi:10.1038/s41591-020-0760-4 · Cited by 5

Detecting synaptic autoantibodies in psychoses: need for more sensitive methods

Masdeu, J. C. (2017) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000447 · Cited by 5

Toxoplasma gondii and Schizophrenia: A Relationship That Is Not Ruled Out

Sorlózano, A., & Fernández, J. G. (2016) · InTech eBooks · doi:10.5772/66018 · Cited by 4

Psychosis: The Utility of Ketamine as a Pharmacological Model of Psychotic-like Symptoms in Rodents: A Review of Dosage Regimens

Rice, C. A., & Stackman, R. W. (2026) · Biology · doi:10.3390/biology15030222 · Cited by 4

Imagerie cérébrale en psychiatrie : indications et résultats

Orliac, F., & Delamillieure, P. (2012) · Encyclopédie médico-chirurgicale. Psychiatrie · doi:10.1016/s0246-1072(12)60525-2 · Cited by 6

The Perspectives of Early Diagnosis of Schizophrenia Through the Detection of Epigenomics-Based Biomarkers in iPSC-Derived Neurons

Lee, D., Seo, J., Jeong, H. C., Lee, H., & Lee, S. B. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.756613 · Cited by 8

Neuroimaging studies in schizophrenia: An overview of research from Asia

Narayanaswamy, J. C., Venkatasubramanian, G., & Gangadhar, B. N. (2012) · International Review of Psychiatry · doi:10.3109/09540261.2012.704872 · Cited by 4

Development of PET and SPECT Radioligands for In Vivo Imaging of NMDA Receptors

Fuchigami, T., Nakayama, M., & Magata, Y. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_19 · Cited by 4

Pharmacology and Neuroscience of Antipsychotic Drugs

Waddington, J. L., O’Tuathaigh, C. M. P., & Remington, G. J. (2010) · doi:10.1002/9781444327298.ch23 · Cited by 4

Dopaminergic Hypothesis of Schizophrenia: A Historical Perspective

Jučaitė, A., & Nyberg, S. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch1 · Cited by 4

Gestational MAM (Methylazoxymethanol) Administration: A Promising Animal Model for Psychosis Onset

Pen, G. L., Bellon, A., Krebs, M., & Jay, T. M. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_2 · Cited by 3

A neural modeling approach to study mechanisms underlying the heterogeneity of visual spatial frequency sensitivity in schizophrenia

Dugan, C., Zikopoulos, B., & Yazdanbakhsh, A. (2024) · Schizophrenia · doi:10.1038/s41537-024-00480-2 · Cited by 5

Mapping Prodromal Psychosis

Fusar‐Poli, P., Borgwardt, S., & McGuire, P. K. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_20 · Cited by 3

The quest for biomarkers in Schizophrenia: from neuroimaging to machine learning

Bajouco, M., Mota, D., Coroa, M., Caldeira, S., Santos, V., & Madeira, N. G. G. F. (2017) · International Journal of Clinical Neurosciences and Mental Health · doi:10.21035/ijcnmh.2017.4(suppl.3).s03 · Cited by 3

What value do NMDA receptor antagonist models of schizophrenia have for novel drug discovery?

Adell, A. (2025) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2025.2562017 · Cited by 2

Glutamatergic Neurotransmission Abnormalities and Schizophrenia

Dwivedi, Y., & Pandey, G. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_13 · Cited by 2

Mouse Models of Schizophrenia

Desbonnet, L. (2015) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-800981-9.00016-x · Cited by 3

Disinhibition of Prefrontal Cortex Neurons in Schizophrenia

Moghaddam, B., & Pehrson, A. L. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_5 · Cited by 2

Clinical Effects of Mirtazapine added to First Generation Antipsychotics in Schizophrenia

Terevnikov, V. (2013) · Työväentutkimus Vuosikirja · Cited by 2

Molecular Imaging in Schizophrenia Spectrum Disorders

Klein, H., Doorduin, J., & van Berckel, B. N. (2020) · PET and SPECT in Psychiatry · doi:10.1007/978-3-642-40384-2_18

A convergent neurological and psychoanalytic view of the concept of regression and mental structure in a case of NMDA receptor encephalitis

Wilner, A., & Aubé, M. (2014) · Neuropsychoanalysis · doi:10.1080/15294145.2014.973437 · Cited by 1

Autoimmune antibody-associated encephalopathy and dementia syndromes

Fredericks, C. A., & Geschwind, M. D. (2016) · Cambridge University Press eBooks · doi:10.1017/9781139924771.023 · Cited by 1

Dysregulation of the cAMP System in Olfactory Neurons in a Model of Schizophrenia Induced by Administration of (+)-MK-801 to Rats

Bigdai, E. V., & Sinegubov, A. A. (2022) · BIOPHYSICS · doi:10.1134/s0006350922020026 · Cited by 1

mGlu2/3 Agonists – a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial

Mosolov, S. N., Ab, S., Незнанов, Н. Г., Tochilov, V. A., Andreev, B. V., Аведисова, А. С., Bardenshteyn, L. M., Gurovich, I., Reznik, A. M., Nb, Z., et al. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9455-0 · Cited by 1

Ketamine and the Dissociatives

Frohlich, J., & Horn, J. D. V. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800212-4.00060-1 · Cited by 1

Autoimmune Psychosis

Dalmau, J. O., & Graus, F. (2022) · Cambridge University Press eBooks · doi:10.1017/9781108696722.020 · Cited by 1

Influenza A virus infection and NMDA receptor function : A behavioral and molecular study of relevance for schizophrenia

Beraki, S. (2008) · Figshare · Cited by 1

Developmental Consequences of N-methyl-D-aspartate Receptor Hypofunction

Milenković, M. (2011) · TSpace (University of Toronto) · Cited by 1

The use of adjuvant L-arginine in schizophrenia: A behavioural and neurochemical analysis

MacKay, M.-A. B. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3zs2kq4m · Cited by 1

Rho kinase inhibitors ameliorate acute methamphetamine-induced cognitive impairment through the cortico-striatal circuit in micePreprint

Liao, J., Wulaer, B., Mizoguchi, H., Sawahata, M., Liu, Y., Dong, G., Kaibuchi, K., Ozaki, N., Nabeshima, T., Nagai, T., et al. (2022) · doi:10.22541/au.166439569.90753669/v1 · Cited by 1

Lateral Septal Circuits Govern Schizophrenia-Like Effects of Ketamine on Social BehaviorPreprint

Wang, R., Peterson, Z. J., Balasubramanian, N., Khan, K. M., Chimenti, M. S., Thedens, D. R., Nickl‐Jockschat, T., & Marcinkiewcz, C. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.08.552372 · Cited by 1

Einfluss von Polymorphismen des DAO-Gens auf Schizophrenie und den Endophänotyp Gedächtnisleistung

Seebach, J. K. (2014) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16712

Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen

Müller, N., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_5

Schizophrenia: Biological Mechanisms

Perrone‐Bizzozero, N. I., & Bullock, W. M. (2008) · Wiley eBooks · doi:10.1002/9780470048672.wecb669

The prefrontal cortex and information processing : nitric oxide signaling studied in an animal model of schizophrenia

Fejgin, K. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University)

Neuroimaging

Fusar‐Poli, P., & McGuire, P. K. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642197.020

Small Molecules that Target Schizophrenia

Martényi, F. (2009) · Wiley Encyclopedia of Chemical Biology · doi:10.1002/9780470048672.wecb685

The relationship between variation in genes, GABA, structureand gamma oscillations in the visual and auditory system ofhealthy individuals and psychiatric disorder

Brealy, J. (2015) · ORCA Online Research @Cardiff (Cardiff University)

Anatomical and Functional Characterization of the Ventral Hippocampus in a Rodent Model of Schizophrenia Neuropathology

Remole, K. E. (2012) · doi:10.7916/d8tt4z19

Development of Radioligands for In Vivo Imaging of NMDA Receptors

Fuchigami, T., Nakayama, M., & Magata, Y. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_18

Nuclear medicine in psychiatry.

Lass, P., & Sławek, J. W. (2007) · PubMed

Functional Roles of Group II Metabotropic Glutamate Receptors in the Hippocampal CA1 Network

Rosenberg, N. (2015) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-010553902

The Effects of Ketamine on the Brain’s Spontaneous Activity as Measured by Temporal Variability and Scale-Free Properties. A Resting-State fMRI Study in Healthy Adults.

Ayad, O. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5979

Tratamento repetido com canabidiol atenua alterações comportamentais e moleculares em um modelo de esquizofrenia baseado no antagonismo dos receptores NMDA

Gomes, F. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-05012016-224242

Drugs that Target the Glutamate Synapse: Implications for the Glutamate Hypothesis of Schizophrenia

Mielnik, C. A., & Ramsey, A. J. (2015) · Royal Society of Chemistry eBooks · doi:10.1039/9781782622499-00115

Efeitos da administração do MK801 na percepção visual da ilusão de Müller-Lyer em primatas não-humanos (Sapajus SPP) : uma contribuição ao estudo experimental da esquizofrenia

Jacobsen, M. E. (2016) · doi:10.26512/2016.02.d.20121

cortex by repeated administration of antipsychotic drugs.

Fumagalli, F., Frasca, A., Racagni, G., & Riva, M. A. (2008)

Mutant and Transgenic Tools in Modeling Schizophrenia

Desbonnet, L., Tomiyama, K., Koshikawa, N., O’Tuathaigh, C. M. P., & Waddington, J. L. (2009) · Neuromethods · doi:10.1007/978-1-60761-474-6_12

d-Serine Signaling and Schizophrenia

Nishikawa, T. (2016) · Springer eBooks · doi:10.1007/978-4-431-56077-7_6

Biomarkers of brain function in psychosis and their genetic basis

Ranlund, S. M. (2016) · UCL Discovery (University College London)

The Effects of Atypical Antipsychotics on Implicit Reward Learning in Schizophrenia

Bradford, L. (2015) · QSpace (Queen's University Library)

Modulation of N-methyl-D-aspartate receptors by Gαs- and Gαi/o-coupled receptors

Trepanier, C. H. (2013) · TSpace (University of Toronto)

Dissociating variations in attention with schizotypy and anxiety

Granger, K. T. (2017) · Nottingham ePrints (University of Nottingham)

Using whole genome sequencing to identify risk alleles for susceptibility to schizophrenia

Davis, G. (2017) · doi:10.7282/t3tt4v31

Untersuchung des Einflusses der LTD-artigen motorkortikalen Plastizität auf die interhemisphärische Konnektivität bei Patienten mit einer Schizophrenie

Aborowa, R. (2018) · doi:10.53846/goediss-6789

Role of the NMDA receptor subunit, NR3A, in glutamatergic synapse development

Henson, M. A. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/s4z0-fd80

Assessing Visual Experience-Dependent Plasticity in Schizophrenia Using Visual Evoked Potentials: an EEG Study

Skaug, K. A. (2018) · NORA - Norwegian Open Research Archives

A Preliminary Study of the Nociceptin Receptor System in Individuals with Psychosis

Khan, M. S. (2019) · TSpace (University of Toronto)

Modeling Schizophrenia in Animals

Feifel, D., & Shilling, P. D. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00023-1

Estudo translacional do receptor N-metil-d-aspartato em primeiro episódio psicótico e em modelos animais de psicose

Loureiro, C. M. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-04082021-134444

D-Serine: Basic Aspects with a Focus on Psychosis

Nishikawa, T., Umino, A., & Umino, M. (2021) · Springer eBooks · doi:10.1007/978-3-319-56015-1_470-1

I disturbi cognitivi nella schizofrenia

Galluzzo, A., Carpi, E., & Crescini, A. (2013) · Springer eBooks · doi:10.1007/978-88-470-2802-9_1

Schizophrenie

Moritz, S., Krieger, E. C., Bohn, F., & Veckenstedt, R. (2017) · Springer eBooks · doi:10.1007/978-3-662-52998-0_2

References: 1986–2011

University College NHS Foundation Trust and University College London (2011) · Springer eBooks · doi:10.1007/978-3-642-25123-8_25

Psychoneurobiology Research and Personalized Treatment of Schizophrenia

Sumiyoshi, T. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-2858-8

Molecular Imaging in Schizophrenia Spectrum Disorders

Klein, H. C., Doorduin, J., & van Berckel, B. N. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_16

Assessing the Acute Effects of CDP-Choline on Sensory Gating and Cognitive Deficits in Chronic Schizophrenia

Aidelbaum, R. (2016) · doi:10.22215/etd/2016-11286

Schizophrenia

Martényi, F. (2012) · Chemical biology · doi:10.1002/9781118435762.ch18

D-Serine: Basic Aspects with a Focus on Psychosis

Nishikawa, T., Umino, A., & Umino, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_470

Role of cryptic rearrangements of human chromosomes in the aetiology of schizophrenia

Jurisova, L., & Šolc, R. (2023) · Journal of Genetics · doi:10.1007/s12041-023-01427-9

Psychiatric disorders

Yang, X., & Lui, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95223-1.00024-2

The Role of the Immune System in Creating Depression, Post-traumatic-Stress-Disorder, and Psychosis

Littrell, J. L. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_2

Recent Progress in NMDA Glutamate Receptor Imaging

Erlandsson, K., & Galovic, M. (2025) · Neuromethods · doi:10.1007/978-1-0716-4494-2_1

Molecular Neuroimaging, Pathophysiological Mechanisms, and Drug Discovery

McGuire, P. K. (2009) · Springer eBooks · doi:10.1007/978-1-4419-0913-8_8

Cognitive Impairment in Schizophrenia: Neurobiological Bases

Martini, F., Spangaro, M., Sapienza, J., Bosia, M., & Cavallaro, R. (2025) · Comprehensive approach to psychiatry · doi:10.1007/978-3-032-06209-3_11

Marqueurs neurodéveloppementaux en psychiatrie : intérêt dans les troubles schizophréniques

Gay, O. (2016) · theses.fr (ABES) · doi:10.70675/b0e8f0f3ze67bz4340z9b3cz01b56b6184f0

The effect of Neuregulin 1 on PCP induced alterations of locomotion, neurotransmission and cell growth as relevant for schizophrenia

Engel, M. (2014) · Research Online (University of Wollongong)

Mnemonic Discrimination Deficits in First-Episode Psychosis and a Ketamine Model Suggest Dentate Gyrus Pathology Linked to NMDA Receptor Hypofunction

Kraguljac, N. V., Carle, M. S., Frölich, M. A., Tran, S., Yassa, M. A., White, D. M., Reddy, A., & Lahti, A. C. (2021) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2021.09.008 · Cited by 12

Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis

Wiescholleck, V., & Manahan‐Vaughan, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.001 · Cited by 54

N-Methyl-D-Aspartate Receptor binding in First-Episode Psychosis: A PET brain imaging study

Beck, K., Arumuham, A., Santangelo, B., Veronese, M., McCutcheon, R. A., Kaar, S. J., McGinnity, C. J., Pillinger, T., Borgan, F., Hammers, A., et al. (2021) · BJPsych Open · doi:10.1192/bjo.2021.79 · Cited by 1

The association between N-methyl-d-aspartate receptor availability and glutamate levels: A multi-modal PET-MR brain imaging study in first-episode psychosis and healthy controls

Beck, K., Arumuham, A., Brugger, S., McCutcheon, R., Veronese, M., Santangelo, B., McGinnity, C., Dunn, J., Kaar, S., Singh, N., et al. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221099643 · Cited by 6

A Pharmacological Model for Psychosis Based on N-methyl-D-aspartate Receptor Hypofunction: Molecular, Cellular, Functional and Behavioral Abnormalities

Rujescu, D., Bender, A., Keck, M. E., Hartmann, A. M., Ohl, F., Ræder, H., Giegling, I., Genius, J., McCarley, R. W., Möller, H., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.029 · Cited by 241